Terbogrel

Terbogrel is a pharmacological agent that is classified as a thromboxane receptor antagonist and thromboxane synthase inhibitor. It is primarily used in the treatment of pulmonary arterial hypertension and other conditions that involve the overproduction of thromboxane.

Pharmacology[edit | edit source]

Terbogrel is a dual thromboxane receptor antagonist and thromboxane synthase inhibitor. This means that it works by blocking the action of thromboxane, a substance in the body that causes blood vessels to narrow and promotes clotting. By inhibiting the production and action of thromboxane, Terbogrel can help to widen blood vessels and prevent blood clots.

Clinical Uses[edit | edit source]

The primary use of Terbogrel is in the treatment of pulmonary arterial hypertension, a condition characterized by high blood pressure in the arteries that supply the lungs. By widening these arteries, Terbogrel can help to reduce blood pressure and improve symptoms.

In addition to pulmonary arterial hypertension, Terbogrel may also be used in the treatment of other conditions that involve the overproduction of thromboxane, such as coronary artery disease and peripheral artery disease.

Side Effects[edit | edit source]

Like all medications, Terbogrel can cause side effects. These may include nausea, vomiting, diarrhea, and abdominal pain. In rare cases, Terbogrel may also cause more serious side effects, such as bleeding or bruising.

See Also[edit | edit source]

Terbogrel Resources
Need Help Finding a Doctor? Need help finding a doctor or specialist anywhere in the world? Explore our world directory. WikiMD's DocFinder can assist you in locating millions of physicians.	Medical Knowledge Access the latest research - Most recent articles Ongoing trials.